Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome.

Hubacek JA, Staněk V, Gebauerová M, Poledne R, Aschermann M, Skalická H, Matoušková J, Kruger A, Pěnička M, Hrabáková H, Veselka J, Hájek P, Lánská V, Adámková V, Piťha J.

Mol Biol Rep. 2015 Mar 26. [Epub ahead of print]

PMID:
25809277
2.

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Lüscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C; Authors/Task Force Members.

Eur Heart J. 2014 Sep 14;35(35):2383-431. doi: 10.1093/eurheartj/ehu282. Epub 2014 Aug 1. No abstract available.

PMID:
25086026
3.

Feasibility of cerebral blood flow and oxygenation monitoring by continuous transcranial Doppler combined with cerebral oximetry in a patient with refractory cardiac arrest treated by extracorporeal life support.

Belohlavek J, Skalicka H, Boucek T, Kovarnik T, Fichtl J, Smid O, Huptych M, Linhart A.

Perfusion. 2014 Nov;29(6):534-8. doi: 10.1177/0267659114529322. Epub 2014 Mar 25.

PMID:
24669002
4.

Prediction of coronary vessel involvement on the basis of atherosclerosis risk factor analysis.

Kovarnik T, Kral A, Skalicka H, Skalicka L, Dostal O, Kralik L, Martasek P, Aschermann M, Horak J, Linhart A, Wahle A, Sonka M.

Bratisl Lek Listy. 2013;114(7):413-7. Review.

PMID:
23822628
5.

The prediction of coronary artery disease based on non-invasive examinations and heme oxygenase 1 polymorphism versus virtual histology.

Kovarnik T, Kral A, Skalicka H, Mintz GS, Kralik L, Chval M, Horak J, Skalicka L, Sonka M, Wahle A, Downe RW, Uhrova J, Benakova H, Cernohousova L, Martasek P, Belohlavek J, Aschermann M, Linhart A.

J Invasive Cardiol. 2013 Jan;25(1):32-7.

6.

Association between a marker on chromosome 9 and acute coronary syndrome. confirmatory study on Czech population.

Hubáček JA, Staněk V, Gebauerová M, Poledne R, Aschermann M, Skalická H, Matoušková J, Kruger A, Pěnička M, Hrabáková H, Veselka J, Hájek P, Lánská V, Adámková V, Pitha J.

Folia Biol (Praha). 2012;58(5):203-8.

8.

Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosis.

Král A, Kovárník T, Králík L, Skalická H, Horák J, Mintz GS, Uhrová J, Sonka M, Wahle A, Downe R, Aschermann M, Martásek P, Linhart A.

Folia Biol (Praha). 2011;57(5):182-90.

9.

Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study.

Kovarnik T, Mintz GS, Skalicka H, Kral A, Horak J, Skulec R, Uhrova J, Martasek P, Downe RW, Wahle A, Sonka M, Mrazek V, Aschermann M, Linhart A.

Circ J. 2012;76(1):176-83. Epub 2011 Nov 10.

10.

Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 and lymphotoxin-alpha genes and acute coronary syndrome in Czech Caucasians.

Hubacek JA, Staněk V, Gebauerová M, Pilipčincová A, Poledne R, Aschermann M, Skalická H, Matoušková J, Kruger A, Pěnička M, Hrabáková H, Veselka J, Hájek P, Lánská V, Adámková V, Pit'ha J.

Exp Clin Cardiol. 2010 Fall;15(3):e52-6.

11.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
12.

A FTO variant and risk of acute coronary syndrome.

Hubacek JA, Stanek V, Gebauerová M, Pilipcincová A, Dlouhá D, Poledne R, Aschermann M, Skalická H, Matousková J, Kruger A, Penicka M, Hrabáková H, Veselka J, Hájek P, Lánská V, Adámková V, Pitha J.

Clin Chim Acta. 2010 Aug 5;411(15-16):1069-72. doi: 10.1016/j.cca.2010.03.037. Epub 2010 Apr 1.

PMID:
20362563
13.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

14.

Apolipoprotein E Arg136 --> Cys in individuals with premature myocardial infarction.

Hubácek JA, Poledne R, Pitha J, Aschermann M, Skalická H, Stanek V.

Folia Biol (Praha). 2009;55(3):116-8.

15.
16.

[Myocardial infarction, left ventricle remodeling and cellular therapy].

Skalická H Jr, Horák J, Aschermann M, Linhart A, Palecek T, Kobylka P.

Vnitr Lek. 2009 Jan;55(1):37-44. Review. Czech.

PMID:
19227954
17.

[Cardiovascular rehabilitation today].

Karel I, Skalická H.

Vnitr Lek. 2009 Jan;55(1):22-6. Review. Czech.

PMID:
19227952
18.

Irbesartan in patients with heart failure and preserved ejection fraction.

Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators.

N Engl J Med. 2008 Dec 4;359(23):2456-67. doi: 10.1056/NEJMoa0805450. Epub 2008 Nov 11.

19.

Intravascular ultrasound assessment of coronary artery involvement in Fabry disease.

Kovarnik T, Mintz GS, Karetova D, Horak J, Bultas J, Skulec R, Skalicka H, Aschermann M, Elleder M, Linhart A.

J Inherit Metab Dis. 2008 Dec;31(6):753-60. doi: 10.1007/s10545-008-0794-0. Epub 2008 Nov 8.

PMID:
18998239
20.

Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.

Widimsky P, Motovská Z, Simek S, Kala P, Pudil R, Holm F, Petr R, Bílková D, Skalická H, Kuchynka P, Poloczek M, Miklík R, Maly M, Aschermann M; PRAGUE-8 Trial Investigators.

Eur Heart J. 2008 Jun;29(12):1495-503. doi: 10.1093/eurheartj/ehn169. Epub 2008 Apr 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk